Ayush P Gandhi
Department of Hospital Medicine, Division of Internal Medicine
Present Title & Affiliation
Primary Appointment
Inpatient Medical Director for Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Inpatient Medical Director, Hospital Medicine, The University of Texas MD Anderson Cancer Center
Education & Training
Degree-Granting Education
| 2009 | M.P. Shah Medical College, Jamnagar, IN, MD |
Postgraduate Training
| 2011-2014 | Clinical Internship, Guthrie/Robert Packer Hospital, Sayre, Pennsylvania |
Licenses & Certifications
| 2021 | Texas State Medical |
| 2021 | New York State Medical License |
| 2014 | American Board of Internal Medicine |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Hospital Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023
Assistant Professor, Mount Sinai Morningside Hospital, New York, NY, 2018
Other Professional Positions
Inpatient Medical Director, The University of Texas MD Anderson Cancer Center, 2025 - Present
Site lead- Hospital at Home program, Mount Sinai Morningside Hospital, New York, NY, 2019
Lead Nocturnis, Mount Sinai Morningside Hospital, New York, NY, 2018 - 2022
Clinical Instructor/Hospitalist, Banner Medical Group, Sun City, AZ, 2014 - 2018
Clinical Instructor/, Banner Del E Webb Medical Center, Sun City, AZ, 2014 - 2018
Honors & Awards
| 2022 | STAR Employee Recognition |
| 2017 | Recognition for Above and Beyond patient care |
Professional Memberships
Selected Publications
Other Articles
- Simbaqueba Clavijo C, Gandhi AP Immunotherapy-Related Adverse Events and Clinical Outcomes in Adult Solid-Tumor Patients Admitted to an Onco-Hospitalist Service. Cancers (Basel). 2025; 17(3):403, 2025.
- Gandhi AP About Secondary Causes of Diabetes Mellitus. J Mississippi State Med Assoc. 2012; 53(11):380–383, 2025.
- Gandhi AP, Bhatt, N, Parhizgar, A. Comparative Renal Safety of Tirzepatide and Semaglutide: An FDA Adverse Event Reporting System (FAERS)—Disproportionality Study. J. Clin. Med. 2025, 14, 7678, 2025.
- Gandhi AP, Master, S, Bhise, V When Nature Meets Oncology: Unraveling Herb–Drug Interactions in Cancer Therapy. Int. J. Mol. Sci. 2025, 26, 10494, 2025.
- Gandhi AP, Parhizgar, A GLP-1 receptor agonists in Alzheimer’s and Parkinson’s disease: Endocrine pathways, clinical evidence, and future directions. Frontiers in Endocrinology, 16, 1708565, 2025.
- Gandhi AP, Jeun R, Wang Z, Khan S, Best C, Lavis V, Thosani S Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis. Cancers (Basel). 2025; 17(2728), 2025. PMID: 403.
- Gandhi AP GLP-1 receptor agonists in Alzheimer’s disease: therapeutic mechanisms and clinical perspectives. Frontiers in Endocrinology, 2025.
- Gelani A, Kakrla M, Gandhi AP, Kotadiya S, Gohil N, Chauhan D, Iswaravaka V, Prashar J, Bamhroliya Z, Doddapaneni VK, Purohit A, Baldaniya N A Case of Herpes Simplex Esophagitis. Poster presented at: AMA Research Challenge 2025; Virtual; 2025, 2025.
- Simbaqueba C, Gandhi AP, Koom Dadzie, K, Halm, J, Dickson, K, Musaelyan, A, Amoateng, D, Doris, Phyu, E, Bogdanich, I, Bhise V, Leal - Alviarez, D, Chua, R, Tomy, S, Manzano, J 1192 Immunotherapy related adverse events and clinical outcomes in adult solid tumor cancer patients on immune checkpoint inhibitors admitted to a tertiary medical center hospitalist medicine service. Journal for ImmunoTherapy of Cancer. 12. A1326-A1326. 10.1136/jitc-2024-SITC2024.1192, 2024.
- Gandhi, Ayush, MD About Secondary Causes of Diabetes Mellitus. Journal of Mississippi state medical association 53(11):380-383, 2012.
- Patel U, Kotadiya S, Kakarla M, Gelani AM, Chauhan D, Iswaravaka V, Gohil N, Prashar J, Bambhroliya Z, Doddapaneni VK, Purohit A, Gandhi AP Genomic Profiling-Based Prognosis and Survival of Colorectal Carcinoma: A Mutation and Survival Analysis From cBioPortal. J Clin Oncol. 2025;43(4_suppl):S412.
- Gandhi AP, Jeun R, Khan S, Best C, Ralph Lavis V, Thosani S SUN-589 Diabetic Ketoacidosis in Cancer Patients: Etiological Patterns in a Tertiary Care Center. J Endocr Soc. 2025 Oct 22;9(Suppl 1):bvaf149.1240. doi: 10.1210/jendso/bvaf149.1240.
Patient Reviews
CV information above last modified July 22, 2026